RECOMBINANT BCG STRAINS EXPRESSING THE SIV(MAC251)NEF GENE INDUCE PROLIFERATIVE AND CTL RESPONSES AGAINST NEF SYNTHETIC PEPTIDES IN MICE

Citation
N. Winter et al., RECOMBINANT BCG STRAINS EXPRESSING THE SIV(MAC251)NEF GENE INDUCE PROLIFERATIVE AND CTL RESPONSES AGAINST NEF SYNTHETIC PEPTIDES IN MICE, Vaccine, 13(5), 1995, pp. 471-478
Citations number
42
Categorie Soggetti
Immunology
Journal title
ISSN journal
0264410X
Volume
13
Issue
5
Year of publication
1995
Pages
471 - 478
Database
ISI
SICI code
0264-410X(1995)13:5<471:RBSETS>2.0.ZU;2-X
Abstract
CTL responses are known to be important for the control of HIV and SIV infections. Such responses are targeted against various components of these viruses including regulatory proteins like Nef. The SIV(mac251) nef gene was cloned in Mycobacterium bovis BCG under the control of P- AN, a promoter from Mycobacterium paratuberculosis. Nef was expressed as a fused polypeptide with ORF2, an open reading frame adjacent to P- AN. Mice inoculate with rBCG(SIV(mac251)nef) exhibited proliferative a nd CD8+ cytotoxic T-cell (CTL) responses against several Nef synthetic peptides. A mapping of the epitopes recognized by CTLs revealed that the central region of Nef is mainly involved in responses. This region had already been demonstrated to induce CTLs in experimentally SIV-in fected macaques as well as in HIV-infected individuals. These results demonstrate the feasibility of constructing BCG vaccine strains expres sing nef for eliciting cytotoxic responses.